El En SpA
MIL:ELN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.4), the stock would be worth €12.52 (4% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.5 | €13 |
0%
|
| 3-Year Average | 2.4 | €12.52 |
-4%
|
| 5-Year Average | 2.7 | €14.13 |
+9%
|
| Industry Average | 2.6 | €13.68 |
+5%
|
| Country Average | 1.8 | €9.61 |
-26%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
|
El En SpA
MIL:ELN
|
1B EUR | 2.5 | 23.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.2B USD | 9.6 | 59.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.3B USD | 3.1 | 25.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 5.6 | 38.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD | 2.2 | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92B USD | 3.8 | 25.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 4.7 | 44.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 2.2 | 19.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.1B USD | 28.4 | 43.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.3B USD | 1.7 | 24.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 5.1 | 21.6 |
Market Distribution
| Min | 0.3 |
| 30th Percentile | 1.3 |
| Median | 1.8 |
| 70th Percentile | 2.7 |
| Max | 362.8 |
Other Multiples
El En SpA
Glance View
El.En.SpA operates as a holding company, which engages in the production, research and development, distribution, and sale of laser systems. The company is headquartered in Calenzano, Firenze. The company went IPO on 2000-12-11. The company controls a group of companies active in the manufacture, research, development, distribution and sale of laser equipment.The Company's range of products includes laser systems for dermatology, surgery, cosmetics, physiotherapy, dentistry and gynaecology, laser systems for cutting, marking and welding of metals, wood, plastic and glass; decoration of leather and fabrics, conservative restoration of works of art. The firm also offers accessories, after-sale services and consulting in the related areas.
